Tempest Therapeutics (TPST) Price to FCF (2012 - 2025)
Tempest Therapeutics' (TPST) quarterly Price to FCF came in at 3.96 in Q4 2025, down 72.49% year-over-year from 14.38 in Q4 2024, and up 41.24% quarter-over-quarter from 6.73 in Q3 2025.
Analysis
Tempest Therapeutics (TPST) Price to FCF (2012 - 2025) Analysis & Trends
Tempest Therapeutics has disclosed Price to FCF across 14 years of filings, most recently posting 3.96 for Q4 2025.
- In Q4 2025, Price to FCF fell 72.49% year-over-year to 3.96; the TTM figure through Dec 2025 stood at 0.53 (up 24.23% YoY), while the FY2025 annual figure was 0.53, up 24.23% from the prior year.
- Price to FCF came in at 3.96 for Q4 2025 at Tempest Therapeutics, up from 6.73 in the prior quarter.
- In the past five years, Price to FCF ranged from a high of 181.51 in Q2 2021 to a low of 11.81 in Q1 2024.
- Average Price to FCF over 5 years is 4.66, with a median of 3.6 recorded in 2021.
- Year-over-year, Price to FCF plunged 519.99% in 2023 and soared 79.09% in 2024.
- Over 5 years, Price to FCF stood at 2.5 in 2021, then rose by 29.15% to 1.77 in 2022, then sank by 519.99% to 10.97 in 2023, then soared by 79.09% to 2.29 in 2024, then sank by 72.49% to 3.96 in 2025.
- Per Business Quant data, the three most recent Price to FCF figures were 3.96 in Q4 2025, 6.73 in Q3 2025, and 3.58 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Tempest Therapeutics | 3.35 Mn | 2.55 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -3.96 |
| Sep 30, 2025 | -6.73 |
| Jun 30, 2025 | -3.58 |
| Mar 31, 2025 | -4.20 |
| Dec 31, 2024 | -2.29 |
| Sep 30, 2024 | -3.65 |
| Jun 30, 2024 | -9.31 |
| Mar 31, 2024 | -11.81 |
| Dec 31, 2023 | -10.97 |
| Sep 30, 2023 | -0.67 |
| Jun 30, 2023 | -2.46 |
| Mar 31, 2023 | -3.82 |
| Dec 31, 2022 | -1.77 |
| Sep 30, 2022 | -2.58 |
| Jun 30, 2022 | -2.61 |
| Mar 31, 2022 | -3.41 |
| Dec 31, 2021 | -2.50 |
| Sep 30, 2021 | -8.46 |
| Jun 30, 2021 | 181.51 |
| Mar 31, 2021 | -3.61 |